Month: November 2020

Nov 20 2020

Uncategorized

Study uses polygenic risk scores to determine schizophrenia risk in patients with chromosome deletion syndrome

by Clinical Editor

No Comments

A new study involving researchers from Children’s Hospital of Philadelphia (CHOP) has uncovered genetic clues that may help identify which patients with chromosome 22q11.2 deletion syndrome (22q11.2DS …

Nov 20 2020

Uncategorized

Long-acting antipsychotic therapy plus cognitive training show promise for schizophrenia

by Clinical Editor

No Comments

Scientists have found that the use of long-acting antipsychotic medication combined with the use of cognitive training in group settings led to improved cognition and increased productivity.

Nov 19 2020

Uncategorized

Abhishek Banerjee On Fighting His Own Demons And Battling With Mom’s Schizophrenia

by Clinical Editor

No Comments

Strong, muscular, tall, macho, suave – we wouldn’t blame you if you thought we were describing a man. The image associated with men has always inclined towards the physical aspect...

Nov 19 2020

Uncategorized

Feinstein Institutes Researchers Help Lead $52M Study of Schizophrenia in High-Risk Youth

by Clinical Editor

No Comments

Researchers from The Feinstein Institutes for Medical Research and two other institutions have been awarded a $52 million, five-year grant from the National Institute of Mental Health (NIMH) to lead...

Nov 19 2020

Uncategorized

U.S. FDA declines to approve Alkermes’ schizophrenia treatment

by Clinical Editor

No Comments

Drugmaker Alkermes said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for schizophrenia and bipolar disorder, citing concerns related to a tablet coating process …

Nov 19 2020

Uncategorized

Year in Review: Schizophrenia

by Clinical Editor

No Comments

In September, the American Psychiatric Association released new recommendations for treatment of schizophrenia– the first update since 2009. Although the guidelines reflect a shift towards shared …

Nov 19 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 19 2020

Uncategorized

Parasite infection discovery could assist mental health treatments

by Clinical Editor

No Comments

New research into how a common parasite infection alters human behavior could help development of treatments for schizophrenia and other neurological disorders. T. gondii currently infects 2.5 billion people worldwide...

Nov 18 2020

Uncategorized

Alkermes flops FDA’s ‘remote review’ at manufacturing site for schizophrenia, bipolar disorder drug – FiercePharma

by Clinical Editor

No Comments

Alkermes flops FDA’s ‘remote review’ at manufacturing site for schizophrenia, bipolar disorder drug  FiercePharma U.S. FDA declines to approve Alkermes’ schizophrenia treatment  Reuters Alkermes’ schizophrenia, bipolar I candidate draws manufacturing CRL |...

Nov 18 2020

Uncategorized

Feinstein Institutes Researchers Help Lead $52M Study of Schizophrenia in High-Risk Youth

by Clinical Editor

No Comments

Researchers from The Feinstein Institutes for Medical Research and two other institutions have been awarded a $52 million, five-year grant from the National Institute of Mental Health (NIMH) to lead...